The only drawback of owning cats is that they have relatively short lifespans, but that could all change.
Cats have been by our side for centuries, providing laughter, comfort, and even health benefits – having a cat can reduce the risk of stroke and heart attacks. Yet, one silent threat looms over our beloved whiskered friends: chronic kidney disease. It typically strikes cats around the age of 10, affecting one in three felines, slowly eroding their kidney function, and diminishing their quality of life.
Currently, cats live for about 15 years on average, but Dr. Miyazaki hopes to change that to 30. His breakthrough is the "AIM" injection, a medication that holds incredible promise for cats suffering from chronic kidney disease. He pinpointed the disease's root cause, leading to this life-changing injection's development.
Although the "AIM" injection is still in the clinical trial phase, it's expected to be available by 2025. It’s designed to both treat and prevent chronic kidney disease, promising a longer lifespan and an enhanced quality of life for our feline friends.
Dr. Miyazaki's commitment extends beyond scientific discovery; he intends to make this life-saving medication affordable for all cat owners, ensuring that no one has to choose between their pet's health and financial stability. Thanks to the dedication and compassion of these brilliant scientists, we can look forward to many more years of shared moments, playful pounces, and unconditional love from our feline companions.